Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians

BACKGROUND: The adoption of oncology biosimilars has been slow in the USA, which may be attributed in part to stakeholder perceptions and lack of operational guidance that supports favorable access to biosimilars. OBJECTIVE: Our objective was to understand the real-world implementation experiences w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingyan, Blinzler, Kelly, Lankin, Joshua, Vijayakumar, Sapna, Maculaitis, Martine C., Shelbaya, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847267/
https://www.ncbi.nlm.nih.gov/pubmed/34822141
http://dx.doi.org/10.1007/s40259-021-00509-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847267/
https://www.ncbi.nlm.nih.gov/pubmed/34822141
http://dx.doi.org/10.1007/s40259-021-00509-3

Ejemplares similares